Aurora Cannabis (ACB) Net Equity Issued and Repurchased (2023 - 2024)

Aurora Cannabis (ACB) posted quarterly Net Equity Issued and Repurchased of $92364.7 for Q3 2024, down 92.81% year-on-year from $1.3 million in Q4 2023, and down 99.66% on a QoQ basis from $27.1 million in Q4 2023.

Aurora Cannabis (ACB) Net Equity Issued and Repurchased (2023 - 2024) Analysis & Trends

Aurora Cannabis (ACB) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $92364.7 the latest figure, recorded in Q3 2024.

  • Quarterly Net Equity Issued and Repurchased fell 92.81% year-over-year to $92364.7 in Q3 2024, while the trailing twelve-month figure through Dec 2024 was $28.4 million (changed N/A YoY) and the FY2023 annual result came in at $1.3 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased slipped to $92364.7 in Q3 2024 per ACB's latest filing, from $27.1 million in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for ACB reached as high as $27.1 million in Q4 2023 and fell as low as $92364.7 in Q3 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 500,000.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 92,364.73
Sep 30, 2024 92,364.73
Dec 31, 2023 27.06 Mn
Dec 31, 2023 27.06 Mn
Sep 30, 2023 1.28 Mn
Sep 30, 2023 1.28 Mn